Access Sub Committee
The UK Biobank Access Sub Committee
Professor Martin Bobrow chairs the UK Biobank Access Sub Committee
Martin was, until he retired, Head of the Department of Medical Genetics. He is Honorary Faculty at the Wellcome Trust Sanger Institute and Emeritus Professor of Medical Genetics, University of Cambridge.
Professor Martin Bobrow, Chair
Professor Andrew Hattersley
Professor Garret Fitzgerald
Professor Ruth Gilbert
The process of reviewing research applications to use UK Biobank is managed by the UK Biobank Coordinating Centre, which conducts a set of standard checks and seeks advice on particular applications as required. Recommendations on each application are made by the UK Biobank Principal Investigator (or their designate) and are subject to confirmation by UK Biobank’s Access Sub-Committee. Applications that raise particular concerns (e.g. involve potentially contentious uses of the resource) will typically be referred to the Access Sub-committee or to UK Biobank’s Board.
The principles established to allow scientific access to UK Biobank are set out in the UK Biobank Ethics & Governance Framework. The detailed requirements of access are set out in the UK Biobank Access Procedures.
The functioning of the Access Procedures will be kept under review by the UK Biobank Principal Investigator (UKBPI), with UK Biobank’s Board and its Access Sub-Committee. Input from the participants, researchers, funders, UK Biobank Ethics Advisory Committee and other interested parties will be taken into account. UK Biobank’s Board will amend the Access Procedures as required on a periodic basis.